# Abbott to build cardiovascular device manufacturing facility in Georgia

Abbott announced plans to build a new cardiovascular device manufacturing facility in Georgia, expected to be completed in 2028. This follows a $500 million investment in U.S. manufacturing and R&D announced in April 2025, creating 300 jobs.

- Type: New facility
- Announced: 2025-08-19
- Where: Georgia, United States
- Value: $500.0M
- Jobs: 300
- Starts operating: 2028
- Status: announced
- Products: cardiovascular devices, transfusion diagnostics, molecular diagnostics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Abbott](https://endata.com/companies/4479.md)

## Sources

- [abbott.com](https://www.abbott.com/en-us/corpnewsroom/strategy-and-strength/investing-in-u-s-manufacturing-to-power-health-tech), 2025-08-19: "Our transfusion medicine, R&D, medical affairs and marketing teams have visited key organizations around the world to understand their pain points."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.